STERIS EPS (Diluted) increased by 1.0% to $1.96 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.0%, from $1.75 to $1.96. Over 3 years (FY 2022 to FY 2025), EPS (Diluted) shows an upward trend with a 37.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher values indicate stronger profitability even when accounting for potential share dilution.
Calculated by dividing net income by the weighted-average number of common shares outstanding, assuming the conversion o...
Used by all public companies to provide a realistic view of earnings per share for investors.
eps_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$0.24 | $0.69 | $1.42 | $0.52 | $1.10 | -$3.15 | $1.24 | $1.88 | $1.25 | $1.16 | $1.42 | -$0.01 | $1.46 | $1.51 | $1.75 | $1.47 | $1.79 | $1.94 | $1.96 |
| QoQ Change | — | +387.5% | +105.8% | -63.4% | +111.5% | -386.4% | +139.4% | +51.6% | -33.5% | -7.2% | +22.4% | -100.7% | >999% | +3.4% | +15.9% | -16.0% | +21.8% | +8.4% | +1.0% |
| YoY Change | — | — | — | — | +558.3% | -556.5% | -12.7% | +261.5% | +13.6% | +136.8% | +14.5% | -100.5% | +16.8% | +30.2% | +23.2% | >999% | +22.6% | +28.5% | +12.0% |